FEATURED ARTICLES

• Achieving A 2.67x Reduction In Study Build Time For An Innovative Neuromodulation Study

  This study explores the potential of Focused Ultrasound Neuromodulation in deepening meditative states, and the platform that helps enhance the overall experience for researchers and participants alike.

• eCOA Evolution: Have We Overcomplicated It?

  eCOA has evolved from simple data collection to complex patient engagement platforms, raising concerns about added complexity. Explore innovative tools aimed at simplifying this complexity.

• Waiver Of Consent vs Waiver Of Written Consent

  Learn the distinctions between a Waiver of Consent and a Waiver of Written Consent in clinical trials, and the importance of informed consent, particularly in the context of virtual trials.

• 5 Best Practices For Getting Started With ePRO

  Unlock the potential of electronic Patient Reported Outcomes (ePRO) in your clinical research by implementing these essential best practices for success.

• Understanding Phase 4 Trials: A Critical Component Of Post-Marketing Insight

  Uncover how Phase 4 trials play an essential role in gathering additional real-world data on the treatment’s performance over a longer period of time and in more diverse patient populations.

• Fulfilling MDR Requirements For A Groundbreaking Microsurgery Robot

  Uncover how Castor accelerated MMI's mission to advance robotic technology and expand the boundaries of open surgery, creating new opportunities for surgeons to restore the quality of life for patients with complex conditions.

• An Expert's View On Choosing And Developing An eCOA Strategy

  Dive into the insights from our recent LinkedIn Live discussion where we explored how a standardized approach to eCOA could transform clinical trials and streamline data collection.

• Do We Still Need Patients In Tomorrow's Trials?

  Delve into how advanced technologies reshape drug development and patient care, and the crucial balance needed between innovation and ethical responsibility to achieve better trial outcomes.

• DTx Company Leverages Real-World Evidence Platform In Registry Study

  Discover how Castor’s eClinical system enabled a groundbreaking study in behavioral disorder treatment to collect Real-World Evidence (RWE) to support product research and claims.

• Navigating The Evolving Regulatory And Data Landscape

  Explore how real-world evidence is reshaping clinical research and learn why precision and innovation are key to staying ahead in this evolving landscape.

• 5 Key Takeaways From The FDA's Real-World Evidence Guidance

  With our advanced technology and expertise, sponsors can confidently conduct RWE studies that are efficient and aligned with the FDA’s data-driven vision for healthcare.

• How Optina Diagnostics Used EDC In Earlier Disease Detection

  Understand how Optina Diagnostics streamlined operations and achieved significant milestones by leveraging Castor's tools in its effort to revolutionize the diagnostic process for Alzheimer’s.

• Measuring The True Patient Experience

  Utilizing the insights covered in this article can inform the design and implementation of cancer trials, ultimately contributing to improved patient care and treatment outcomes.

• ISR Report Sheds Light On eCOA/ePRO Market Dynamics

  This comprehensive overview highlights the critical role these platforms play in modern clinical research, emphasizing their impact on data integrity and trial efficiency.

• eConsent Readiness In 24 Countries

  Discover how regulatory bodies worldwide, including the U.S. Food and Drug Administration and the European Medicines Agency, are now championing the shift towards eConsent adoption.

• 10 FAQs On eConsent

  Closely examine the challenges of adoption, integration, and compliance measures involving eConsent and gain valuable insights for those contemplating their incorporation in clinical trials.

• Essity Uses eConsent To Optimize Enrollment

  See how a global hygiene and health company was able to deploy virtual methods through a strategic partnership to recruit and retain participants, streamline consent, and analyze patient data.

• How Electronic Source Data Revolutionizes Clinical Research

  By increasing interoperability and embracing digital solutions, see how the research community can maximize the benefits offered by eSource, leading to improved trial outcomes and data quality.

• Preparing Studies With eConsent For IRB Approval

  Understand how eConsent can benefit trials and align with IRB ethical commitments, how to prepare your IRB submission for approval, and the future impact of large language models.

• Unlocking The Power Of Real-World Evidence In FDA Submissions

  Understand the gaps between how data is collected in real-world evidence (RWE) and randomized clinical trials (RCT) and how RWE is quickly finding ways to catch up.